When AbbVie ($ABBV) announced its plans for a $320 million bulk manufacturing facility in Singapore in February, it said it would be its first in Asia when it was ...
Strong R&D investment, advanced manufacturing technologies, and supportive government policies accelerate global API production growth.Austin, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Small Molecule ...
The move would dismantle the existing system under which bulk drugs and finished formulations operate under a common licence ...
Mumbai: Softening prices of active pharmaceutical ingredients (API) are likely to stabilise in the months ahead and bring relief to Indian manufacturers, but they will still have to improve their ...
JERUSALEM-- (BUSINESS WIRE)--Teva announced the appointment of John Nason to President, Teva Active Pharmaceutical Ingredients (TAPI), a role in which he leads the company’s vertically integrated ...
CDMO Albany Molecular Research Inc., which was recently acquired by private investors, has bulked up its aseptic API capacity as it continues to expand globally. The Albany, New York, contractor says ...
New Delhi: Spain is looking to invest in bulk drug parks in India in a move that could help diversify both their active pharmaceutical ingredients (API) supply chains. Bulk drugs are used for ...
UP govt to discuss Lalitpur bulk drugs park with pharma companies in Telangana on Jan 6: Shardul Nautiyal, Mumbai Tuesday, January 6, 2026, 08:00 Hrs [IST] To boost self-reliance ...